| Mechanical stress-induced mast cell degranulation activates TGF-â1 signalling pathway in pulmonary fibrosis C Shimbori, C Upagupta, PS Bellaye, EA Ayaub, S Sato, T Yanagihara, ... Thorax 74 (5), 455-465, 2019 | 81 | 2019 |
| DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation M Watanabe, M Terasawa, K Miyano, T Yanagihara, T Uruno, ... The Journal of Immunology 193 (11), 5660-5667, 2014 | 66 | 2014 |
| Macitentan reduces progression of TGF-â1-induced pulmonary fibrosis and pulmonary hypertension PS Bellaye, T Yanagihara, E Granton, S Sato, C Shimbori, C Upagupta, ... European Respiratory Journal 52 (2), 2018 | 55 | 2018 |
| Synergistic role of HSP90á and HSP90â to promote myofibroblast persistence in lung fibrosis PS Bellaye, C Shimbori, T Yanagihara, DA Carlson, P Hughes, ... European Respiratory Journal 51 (2), 2018 | 51 | 2018 |
| Connective-tissue growth factor contributes to TGF-â1–induced lung fibrosis T Yanagihara, K Tsubouchi, M Gholiof, SG Chong, KE Lipson, Q Zhou, ... American journal of respiratory cell and molecular biology 66 (3), 260-270, 2022 | 50 | 2022 |
| Amphiregulin suppresses epithelial cell apoptosis in lipopolysaccharide-induced lung injury in mice S Ogata-Suetsugu, T Yanagihara, N Hamada, C Ikeda-Harada, ... Biochemical and Biophysical Research Communications 484 (2), 422-428, 2017 | 49 | 2017 |
| Current models of pulmonary fibrosis for future drug discovery efforts T Yanagihara, SG Chong, M Vierhout, JA Hirota, K Ask, M Kolb Expert opinion on drug discovery 15 (8), 931-941, 2020 | 46 | 2020 |
| What have we learned from basic science studies on idiopathic pulmonary fibrosis? T Yanagihara, S Sato, C Upagupta, M Kolb European Respiratory Review 28 (153), 2019 | 46 | 2019 |
| The Rac activator DOCK2 regulates natural killer cell–mediated cytotoxicity in mice through the lytic synapse formation Y Sakai, Y Tanaka, T Yanagihara, M Watanabe, X Duan, M Terasawa, ... Blood, The Journal of the American Society of Hematology 122 (3), 386-393, 2013 | 45 | 2013 |
| Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia T Ogura, N Takigawa, K Tomii, K Kishi, Y Inoue, E Ichihara, S Homma, ... Respiratory investigation 57 (6), 512-533, 2019 | 43 | 2019 |
| Intronic regulation of Aire expression by Jmjd6 for self-tolerance induction in the thymus T Yanagihara, F Sanematsu, T Sato, T Uruno, X Duan, T Tomino, ... Nature communications 6 (1), 8820, 2015 | 40 | 2015 |
| Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade Oncotarget 9, 30587-30593, 2018 | 27 | 2018 |
| Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease K Suzuki, T Yanagihara, K Matsumoto, H Kusaba, T Yamauchi, ... International immunology 32 (8), 547-557, 2020 | 26 | 2020 |
| Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update A Wongkarnjana, T Yanagihara, MRJ Kolb Expert Review of Respiratory Medicine 13 (12), 1139-1146, 2019 | 20 | 2019 |
| Expression of endocannabinoid system components in human airway epithelial cells: Impact of sex and chronic respiratory disease status MF Fantauzzi, JA Aguiar, BJM Tremblay, MJ Mansfield, T Yanagihara, ... ERJ open research 6 (4), 2020 | 18 | 2020 |
| Therapeutic targets and early stage clinical trials for pulmonary fibrosis S Sato, T Yanagihara, MRJ Kolb Expert Opinion on Investigational Drugs 28 (1), 19-28, 2019 | 18 | 2019 |
| Recurrent idiopathic pulmonary hemosiderosis after long-term remission presented with Sjogren's syndrome: Idiopathic no more? T Yanagihara, Y Yamamoto, N Hamada, K Suzuki, S Ogata-Suetsugu, ... Respiratory medicine case reports 25, 68-72, 2018 | 18 | 2018 |
| Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-naphthalene-induced acute pneumonitis in mice H Mikumo, T Yanagihara, N Hamada, E Harada, S Ogata-Suetsugu, ... Biochemical and biophysical research communications 486 (1), 205-209, 2017 | 17 | 2017 |
| Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment T Yanagihara, K Tanaka, K Ota, E Kashiwagi, A Takeuchi, K Tatsugami, ... Annals of Oncology 28 (8), 2038-2039, 2017 | 16 | 2017 |
| Insights into potential pathogenesis and treatment options for immune-checkpoint inhibitor-related pneumonitis H Ando, K Suzuki, T Yanagihara Biomedicines 9 (10), 1484, 2021 | 15 | 2021 |
Martin KolbProfessor of Medicine, McMaster University HamiltonVerified email at mcmaster.ca
